Definium TherapeuticsDFTX
那斯達克 · USD
34.24
-0.14
(-0.41%)
收盤 10/15 03:59 (UTC+8)
盤後
34.10
34.10
(-0.41%)
10/15 03:59 (UTC+8)
Definium TherapeuticsDFTX
34.24
-0.14
(-0.41%)
財務數據
損益表
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2026/Q2 | 2026/Q1 | 2025/Q4 | 2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | |
營業收入淨額 | - | - | - | - | - | - | - | - |
營業成本 | - | - | - | - | - | - | - | - |
營業毛利 | - | - | - | - | - | - | - | - |
營業費用 | 75,077 | 59,220 | 47,578 | 45,669 | 40,903 | 32,159 | 32,462 | 24,792 |
研發費用 | 48,665 | 41,484 | 33,521 | 30,978 | 29,809 | 23,357 | 21,759 | 17,188 |
推銷及管理費用 | 26,412 | 17,736 | 14,057 | 14,691 | 11,094 | 8,802 | 10,703 | 7,604 |
非經常性項目費用 | - | - | - | - | - | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - |
營業利益 | -75,077 | -59,220 | -47,578 | -45,669 | -40,903 | -32,159 | -32,462 | -24,792 |
其他收入及費用 | -82,676 | -16,633 | -1,590 | -20,322 | 497 | 9,413 | -1,623 | - |
利息費用 | 1,233 | 1,245 | 1,268 | 1,274 | 2,338 | 602 | 656 | 727 |
稅前純益 | -158,986 | -77,098 | -50,436 | -67,265 | -42,744 | -23,348 | -34,741 | -13,684 |
所得稅 | - | - | - | - | - | - | - | - |
稅後純益 | -158,986 | -77,098 | -50,436 | -67,265 | -42,744 | -23,348 | -34,741 | -13,684 |
基本每股稅後盈餘(元) | -1.44 | -0.71 | -0.51 | -0.78 | -0.50 | -0.27 | -0.41 | -0.18 |
稀釋每股稅後盈餘(元) | -1.44 | -0.71 | -0.50 | -0.75 | -0.46 | -0.35 | -0.42 | -0.11 |
基本平均股數(千股) | 110684.00 | 108790.00 | 101011.00 | 85885.00 | 85347.00 | 85067.00 | 83931.00 | 77909.00 |
稀釋平均股數(千股) | 110684.00 | 108790.00 | 98987.00 | 85885.00 | 85347.00 | 87091.00 | 83931.00 | 80238.00 |
還原基本每股稅後盈餘(元) | -1.44 | -0.71 | -0.51 | -0.78 | -0.50 | -0.27 | -0.41 | -0.18 |
還原稀釋每股稅後盈餘(元) | -1.44 | -0.71 | -0.50 | -0.75 | -0.46 | -0.35 | -0.42 | -0.11 |
還原基本平均股數(千股) | 110,684 | 108,790 | 101,011 | 85,885 | 85,347 | 85,067 | 83,931 | 77,909 |
還原稀釋平均股數(千股) | 110,684 | 108,790 | 98,987 | 85,885 | 85,347 | 87,091 | 83,931 | 80,238 |
EBITDA(千元) | -159,117 | -75,262 | -48,710 | -65,848 | -42,828 | -22,746 | -33,360 | -12,957 |